Lorlatinib als vielversprechendes Medikament in der zukünftigen Therapie des fortgeschrittenen ALK-positiven nichtkleinzelligen Bronchialkarzinoms
| Autor: | Johanna Richter, Jürgen Dunst |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Drug
Oncology medicine.medical_specialty Lung Neoplasms Lactams Lactams Macrocyclic media_common.quotation_subject medicine.medical_treatment Aminopyridines Text mining Carcinoma Non-Small-Cell Lung Internal medicine Humans Medicine Radiology Nuclear Medicine and imaging Lung cancer Protein Kinase Inhibitors Radiotherapy media_common business.industry ALK-Positive Receptor Protein-Tyrosine Kinases medicine.disease Lorlatinib Radiation therapy Pharmaceutical Preparations Pyrazoles Non small cell business Literatur Kommentiert |
| Zdroj: | Strahlentherapie Und Onkologie |
| ISSN: | 1439-099X 0179-7158 |
| DOI: | 10.1007/s00066-021-01788-z |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink